1. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

   • W. J. Heinz
   • D. Buchheidt
   • G. Maschmeyer

   Review Article Open access 30 August 2017 Pages: 1775 - 1792

   

2. Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia

   • Yinjun Lou
   • Yafang Ma
   • Jie Jin

   Original Article 19 August 2017 Pages: 1793 - 1800

   

3. Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy

   • Sang-Bo Oh
   • Sung-Woo Park
   • on behalf of the Hematology Association of South-East Korea (HASEK) study group

   Original Article 21 August 2017 Pages: 1801 - 1809

   

4. A comparison of therapeutic dosages of decitabine in treating myelodysplastic syndrome: a meta-analysis

   • Bo Yang
   • Ruili Yu
   • Xuechun Lu

   Original Article 25 August 2017 Pages: 1811 - 1823

   

5. Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP™) as epigenetic treatment for myelodysplastic syndrome (MDS)

   • Myrna Candelaria
   • Sebastian Burgos
   • Alfonso Dueñas-Gonzalez

   Original Article 23 August 2017 Pages: 1825 - 1832

   

6. The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment

   • Natalia Lorenzana
   • Laura Francisca Avila
   • Teresa Bernal

   Original Article 13 August 2017 Pages: 1833 - 1840

   

7. A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation

   • Tomoko Sato
   • Takaaki Konuma
   • Arinobu Tojo

   Original Article 16 August 2017 Pages: 1841 - 1847

   

8. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation

   • Jiaqian Qi
   • Jie Wang
   • Yue Han

   Original Article 11 August 2017 Pages: 1849 - 1855

   

9. Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study

   • Martin Kropff
   • Martin Vogel
   • Wolfgang E. Berdel

   Original Article 14 September 2017 Pages: 1857 - 1866

   

10. Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations

    • Xin-xin Cao
    • Jian Li
    • Dao-bin Zhou

    Original Article 12 August 2017 Pages: 1867 - 1871

    

11. Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores

    • Hyewon Lee
    • Yu Ri Kim
    • Jin Seok Kim

    Original Article 22 August 2017 Pages: 1873 - 1881

    

12. PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma

    • Young Wha Koh
    • Jae-Ho Han
    • Jooryung Huh

    Original Article 25 August 2017 Pages: 1883 - 1890

    

13. Uterine intravascular lymphoma as a cause of fever of unknown origin

    • Jérôme Hadjadj
    • Hubert Nielly
    • David Boutboul

    Original Article 29 August 2017 Pages: 1891 - 1896

    

14. Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly

    • A. Partanen
    • J. Valtola
    • E. Jantunen

    Original Article 07 September 2017 Pages: 1897 - 1906

    

15. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia

    • Elias H. Atta
    • Carlos B. L. Lima
    • Phillip Scheinberg

    Original Article 16 August 2017 Pages: 1907 - 1914

    

16. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients

    • Hiroyuki Tsuda
    • Takahiro Tsuji
    • Hiroshi Yamasaki

    Original Article 14 August 2017 Pages: 1915 - 1920

17. Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia

    • José Ferrão
    • Marisa Silva
    • Paula Faustino

    Original Article 08 September 2017 Pages: 1921 - 1929

    

18. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT)

    • D. Maira
    • E. Cassinerio
    • M. D. Cappellini

    Original Article 05 September 2017 Pages: 1931 - 1936

    

19. Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients

    • Philippos Klonizakis
    • Robert Klaassen
    • Efthymia Vlachaki

    Original Article 07 September 2017 Pages: 1937 - 1944

    

20. Effects of realgar (As₄S₄) on degradation of PML-RARA harboring acquired arsenic-resistance mutations

    • Mingshan Niu
    • Yangling Shen
    • Kailin Xu

    Letter to the Editor 18 August 2017 Pages: 1945 - 1948

    

21. Somatic mutations of calreticulin in patients with myelodysplastic/myeloproliferative neoplasms-unclassifiable

    • Xueya Zhang
    • Jingxin Pan

    Letter to the Editor 17 August 2017 Pages: 1949 - 1951

    

22. Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia

    • Alessandra Iurlo
    • Cristina Bucelli
    • Agostino Cortelezzi

    Letter to the Editor 19 August 2017 Pages: 1953 - 1954

    

23. A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review

    • Tohru Fujiwara
    • Noriko Fukuhara
    • Hideo Harigae

    Letter to the Editor 24 August 2017 Pages: 1955 - 1957

    

24. Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma

    • C. Phipps
    • K. W. Yeoh
    • N. F. Grigoropoulos

    Letter to the Editor 22 August 2017 Pages: 1959 - 1960

    

25. Relative abundance of β-thalassemia-related mutations in southern China correlates with geographical coordinates

    • Yingying Zhao
    • Shenming Guan
    • Le Cheng

    Letter to the Editor 05 September 2017 Pages: 1961 - 1963